Maxcyte (MXCT) Total Debt (2020)
Maxcyte (MXCT) posted quarterly Total Debt of $4.9 million for Q4 2020.
Maxcyte (MXCT) Total Debt (2020) Analysis & Trends
Maxcyte (MXCT) has reported Total Debt for 1 consecutive years, with $4.9 million the latest figure, recorded in Q4 2020.
- In Q4 2020, Total Debt changed N/A year-over-year to $4.9 million; the TTM figure through Dec 2020 stood at $4.9 million (changed N/A YoY), while the FY2020 annual figure was $4.9 million, changed N/A from the prior year.
- Total Debt held at $4.9 million in Q4 2020 per MXCT's latest filing.
- Across five years, Total Debt topped out at $4.9 million in Q4 2020 and bottomed at $4.9 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | 32.61 Bn |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | 14.94 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 27.96 Bn |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | 12.62 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 10.10 Bn |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | 8.68 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 1.89 Bn |
| 10 | Maxcyte | 147.42 Mn | 147.42 Mn | 5.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 4.92 Mn |